1. What clonidine is
Clonidine is an alpha-2 adrenergic agonist, originally developed in the 1960s as a blood pressure medication. Its use for ADHD (and tic disorders, PTSD, hot flashes, opioid withdrawal, various other indications) followed from the recognition that alpha-2 activation has broader nervous-system calming effects.
Available forms:
- Immediate-release tablets. The original form. Multiple daily doses required.
- Extended-release tablets (Kapvay). Once or twice daily. Approved for ADHD in children/adolescents.
- Transdermal patches (Catapres-TTS). 7-day continuous delivery. Steady blood levels.
For ADHD specifically, Kapvay (extended-release) is the FDA-approved form for paediatric ADHD; adult use is generally off-label but well-established clinically.
2. How it works
Clonidine activates alpha-2 adrenergic receptors throughout the brain. The receptor subtypes include:
- Alpha-2A. Concentrated in prefrontal cortex, involved in attention regulation, working memory, executive function. This is the receptor subtype that guanfacine (Intuniv) targets selectively.
- Alpha-2B and 2C. Other brain regions and peripheral tissues. Involved in broader sedation, cardiovascular regulation, sympathetic nervous system modulation.
By activating all three subtypes, clonidine produces:
- Prefrontal cortex function support (the ADHD-relevant effect)
- Broader sedation (the sleep-relevant effect)
- Reduced sympathetic arousal (the PTSD-relevant effect)
- Lower heart rate and blood pressure
- Reduced sensory amplification
- Tic suppression
The broader receptor action is why clonidine is less ADHD-specific than Intuniv but more useful for ADHD accompanied by sleep, sensory, or tic problems.
3. Clonidine vs Intuniv
The key comparison:
- Receptor selectivity. Guanfacine selective for alpha-2A; clonidine acts on broader alpha-2 receptors.
- Sedation. Clonidine more sedating overall; Intuniv produces less sedation at therapeutic doses.
- Half-life. Intuniv 16-18 hours (once-daily); clonidine immediate-release 12-16 hours (multiple doses); clonidine extended-release similar to Intuniv.
- ADHD efficacy. Intuniv generally edges out clonidine for ADHD symptoms specifically.
- Sleep effects. Both improve sleep but clonidine’s stronger sedation makes it more useful for severe insomnia.
- Tic suppression. Both effective; clonidine has longer track record.
- Cost. Generic clonidine very cheap; Intuniv often more expensive depending on insurance.
- FDA approval. Both approved for paediatric ADHD; both off-label for most adults.
See our Intuniv for ADHD guide for the deep-dive on guanfacine.
4. When clonidine is the right choice
Specific scenarios where clonidine is often preferred over Intuniv:
- ADHD with severe insomnia. Bedtime clonidine often dramatically improves sleep onset.
- ADHD with prominent sensory dysregulation. The broader calming reduces sensory amplification.
- ADHD with Tourette’s or chronic tics. Clonidine has longer track record for tic suppression.
- ADHD with PTSD or trauma-related hyperarousal. Alpha-2 activation specifically reduces sympathetic arousal.
- Intuniv intolerance. Sometimes the broader receptor profile suits better.
- Substance-use history. Non-controlled substance; sometimes preferred over stimulants entirely.
- Cardiovascular contraindications to stimulants. Clonidine lowers BP (potentially useful for hypertensive patients; problematic for normotensive).
- Cost considerations. Generic clonidine is very cheap.
5. Dosing approaches
Clonidine dosing is highly individualised. Typical adult approaches:
- Immediate-release for ADHD: 0.05-0.1mg starting dose, titrating to typical maintenance 0.1-0.3mg per dose, divided 2-4 times daily. Total daily dose usually 0.2-0.6mg.
- Kapvay (extended-release): 0.1mg at bedtime starting, titrating to 0.2-0.4mg total daily (usually divided morning + bedtime).
- Sleep-only use: Often 0.05-0.1mg at bedtime. Some adults find this enough to substantially improve sleep without daytime sedation.
- Tic suppression: Variable; often started at 0.05mg and titrated based on tic response.
Titration approach: gradual. Too-fast escalation produces severe sedation, dizziness, and orthostatic hypotension. Most prescribers titrate over 1-3 weeks to reach effective dose.
6. Side-effect profile
Common side effects:
- Sedation. The most-cited side effect. Often substantial during titration; many adults tolerate it only at bedtime.
- Dry mouth
- Constipation
- Dizziness on standing (orthostatic hypotension)
- Fatigue
- Sometimes erectile dysfunction
- Sometimes mood changes or irritability
Cardiovascular effects:
- Lowers blood pressure (intended if hypertensive, problematic if normotensive)
- Slows heart rate
- Risk of rebound hypertension if stopped abruptly (see §13)
Less common but important:
- Depression in some adults
- Vivid dreams
- Significant orthostatic effects
- Withdrawal syndrome if stopped abruptly
7. The sedation factor
Sedation is clonidine’s defining side effect. More than Intuniv, more than atomoxetine, more than most other ADHD medications.
Patterns:
- Strongest during titration (first 2-4 weeks)
- Often substantial enough to preclude daytime use
- Some adults adapt to the sedation; others find it persistent
- Bedtime-only dosing is the most common pattern for this reason
The sedation isn’t universally bad — for ADHD adults with severe insomnia or hyperarousal, the side effect is the treatment goal. The mismatch happens for adults who need ADHD treatment without sedation, where Intuniv or non-alpha-2 options often suit better.
8. Clonidine for ADHD sleep
One of clonidine’s strongest use cases. Bedtime clonidine often produces substantial sleep improvements for ADHD adults with severe insomnia:
- Reduces racing thoughts at bedtime
- Faster sleep onset
- Through-the-night continuity often improves
- Reduces the alert-state ADHD adults often run with
- For ADHD with delayed sleep phase, can partially shift sleep window earlier
Many prescribers use bedtime clonidine specifically for the sleep benefit alongside ADHD or alone. The off-label use for ADHD-related insomnia is well-established clinically. Doses for sleep tend to be lower than for full ADHD treatment (0.05-0.1mg vs 0.1-0.3mg per dose).
9. Clonidine for tics
Clonidine has solid evidence for tic suppression in Tourette’s syndrome and chronic tic disorders.
Use cases:
- First-line tic medication for mild-to-moderate tics
- When stimulant treatment exacerbates tics (common problem with combined ADHD+Tourette’s)
- Combination with stimulant to address both ADHD and tics
- For severe tics, sometimes alongside antipsychotics (though clonidine is generally preferred where adequate)
Effect sizes for tic suppression are moderate but consistent. See our Tourette syndrome guide for the full picture on tic management.
10. Clonidine for ADHD+PTSD
The alpha-2 activation that helps ADHD also addresses the sympathetic-arousal pattern central to PTSD. For adults with both conditions, clonidine can be particularly useful.
Effects on PTSD-related symptoms:
- Reduces hypervigilance
- Improves sleep disturbance from nightmares or anxiety
- Reduces autonomic dysregulation
- Lowers the constant alert-state that drives both ADHD fatigue and PTSD exhaustion
- Sometimes reduces nightmare frequency
Prazosin (an alpha-1 antagonist — a different mechanism from clonidine’s alpha-2 agonism) is more PTSD-specifically targeted, but clonidine’s broader ADHD-relevant effects make it useful when both conditions need addressing simultaneously. Combined ADHD-PTSD treatment often includes clonidine as one component.
11. Combination with stimulants
Stimulant + clonidine combination is common clinical practice for ADHD. The combination addresses different dimensions: stimulant covers attention/hyperactivity; clonidine addresses sleep, sensory regulation, tics, or PTSD-related hyperarousal.
Cardiovascular monitoring is important:
- Stimulants raise heart rate and blood pressure
- Clonidine lowers heart rate and blood pressure
- Net effect varies by patient; can produce balanced effects or unexpected swings
- Baseline and follow-up vital signs typically monitored
Don’t self-combine. This is a prescriber decision with monitoring requirements.
12. The transdermal patch
Catapres-TTS is a clonidine transdermal patch delivering continuous medication over 7 days. Used clinically when oral dosing isn’t practical:
- Compliance issues with multiple daily doses
- GI absorption problems
- Swallowing difficulty
- Preference for steadier blood levels than oral peaks/troughs
Advantages:
- Steady blood levels
- Potentially fewer fluctuation-related side effects
- Once-weekly application instead of multiple daily doses
Disadvantages:
- More expensive than tablets
- Skin irritation possible
- Less common; some pharmacies don’t stock it
- If patch falls off, dosing is interrupted
13. Stopping safely (rebound hypertension risk)
Clonidine should never be stopped abruptly. The cardiovascular rebound is severe and potentially dangerous.
What happens if stopped abruptly:
- Rebound hypertension. Blood pressure can rise to dangerously high levels — sometimes hypertensive crisis requiring emergency care.
- Rebound tachycardia. Heart rate spikes.
- Headache, anxiety, agitation, sweating.
- Symptoms within 18-36 hours of last dose.
Standard discontinuation: gradual taper over 2-4 weeks under medical supervision. Typically reducing daily dose by 25% per week or as prescriber directs. For higher doses or longer treatment duration, slower taper may be appropriate.
Never stop clonidine abruptly without prescriber guidance. Missing doses also carries risk — if you miss a dose, take the next one as scheduled rather than doubling up, and maintain regular dosing.
14. Questions for your prescriber
If considering clonidine for ADHD, useful questions:
- Is clonidine appropriate given my full medical history?
- Immediate-release or Kapvay (extended-release)?
- What dose and titration timeline are we targeting?
- What time of day should I dose?
- What side effects should I watch for?
- How long before I should expect benefit?
- How does this fit with my sleep / tics / anxiety / other conditions?
- Can I combine with stimulants if needed?
- What’s the taper protocol if we stop?
- Are there interactions with my other medications?
15. FAQ
What is clonidine?
Clonidine is an alpha-2 adrenergic agonist, originally developed in the 1960s as a blood pressure medication. Like Intuniv (guanfacine), it’s been repurposed for ADHD because of its effects on prefrontal cortex function. It acts on broader alpha-2 receptors than guanfacine — both alpha-2A (prefrontal cortex) and alpha-2B/C (other regions). The wider receptor profile produces more sedation, more cardiovascular effects, and broader nervous-system calming than guanfacine. Available as immediate-release tablets, extended-release tablets (Kapvay), and transdermal patches (Catapres-TTS).
How does clonidine differ from Intuniv (guanfacine)?
Both are alpha-2 agonists used for ADHD, but they have distinct profiles. Guanfacine is more selective for alpha-2A receptors (prefrontal cortex specifically), producing better attention effects with less sedation. Clonidine acts more broadly on alpha-2 receptors, producing more sedation and broader nervous-system calming. Practical implication: Intuniv often better for pure ADHD attention; clonidine often better for ADHD with severe insomnia, sensory dysregulation, or tic disorders where the broader sedation is useful. Immediate-release clonidine has a shorter duration of clinical action, so it needs several daily doses or an extended-release form (Kapvay); Intuniv is once-daily.
When is clonidine prescribed for ADHD?
Specific patient profiles: ADHD with severe insomnia where bedtime clonidine helps sleep onset; ADHD with prominent sensory dysregulation; ADHD with Tourette’s or tic disorders (clonidine is well-established for tic suppression); ADHD adults who haven’t tolerated Intuniv (sometimes the broader receptor profile suits better); ADHD with PTSD or trauma-related hyperarousal; ADHD with co-occurring substance-use history where stimulants are contraindicated. Clonidine is rarely first-line for ADHD alone but is often the right choice when sleep, sensory, or tic regulation is the dominant problem.
What’s the typical dose?
Highly individualised. Immediate-release clonidine: starting 0.05-0.1mg, titrating to typical maintenance 0.1-0.3mg per dose, usually divided into 2-4 doses daily. Extended-release (Kapvay): 0.1mg starting, titrating to 0.2-0.4mg daily total. For sleep-only use: often 0.05-0.1mg at bedtime. Children/adolescents have weight-adjusted dosing. This is firmly a prescriber conversation — dosing varies substantially with individual response and what symptoms are being targeted.
What are the side effects?
Common: sedation (often substantial, especially during titration); dry mouth; constipation; dizziness on standing (orthostatic hypotension); fatigue; sometimes erectile dysfunction; sometimes irritability or mood changes. Cardiovascular: lowers blood pressure (intended if hypertensive, can be problematic if normotensive); slows heart rate; risk of rebound hypertension if stopped abruptly. Less common but important: depression in some adults; vivid dreams; significant orthostatic effects. Sedation is the most-limiting side effect for daytime use; many adults can only tolerate clonidine at bedtime.
Is clonidine sedating?
Substantially, yes — more sedating than Intuniv (guanfacine). The sedation is often the limiting factor for daytime use. Many adults take clonidine only at bedtime for this reason, accepting that they’re effectively using it as a sleep medication with ADHD-relevant secondary benefits. Some adults adapt to the sedation over 2-4 weeks and can tolerate daytime dosing; others find the sedation persistent. The sedating profile is why clonidine works well for ADHD with severe insomnia — the side effect aligns with treatment goal.
Can clonidine be combined with stimulants?
Yes, and this is common clinical practice. The combination addresses different ADHD dimensions: stimulant for attention/hyperactivity; clonidine for sleep, sensory dysregulation, tics, or PTSD-related hyperarousal. Cardiovascular monitoring is important when combining (stimulants raise heart rate and blood pressure; clonidine lowers them — net effect varies). Most prescribers carefully monitor both vital signs when initiating combination therapy. Don’t self-combine; this is a prescriber decision.
Does clonidine help with tics?
Yes — clonidine has solid evidence for tic suppression in Tourette’s syndrome and chronic tic disorders, including in patients with co-occurring ADHD. Effect sizes are moderate but consistent. Clonidine is often used as first-line tic medication for adults with mild-to-moderate tics, particularly when stimulant treatment is exacerbating tics. Combination of stimulant + clonidine can address both ADHD and tics simultaneously. See our Tourette syndrome guide.
Is clonidine addictive?
No — clonidine has essentially no addiction potential. It’s not a controlled substance. However, physical dependence develops and the medication should be tapered rather than stopped abruptly. Sudden discontinuation produces dangerous rebound hypertension and tachycardia — sometimes severe enough to require emergency care. Always taper under medical supervision. The physical dependence is the body adapting to suppressed alpha-2 signalling, not the addictive pattern of stimulant misuse.
What’s the clonidine patch?
Catapres-TTS is a transdermal patch delivering clonidine continuously over 7 days. Used clinically when oral dosing isn’t practical (compliance issues, GI absorption problems, swallowing difficulty). The patch produces steadier blood levels than oral dosing, potentially fewer fluctuation-related side effects. Sometimes used for ADHD adults who struggle with multiple daily doses or who experience side-effect peaks from oral medication. Cost is typically higher than tablets. This is firmly a prescriber decision.
Can clonidine help with PTSD-related ADHD symptoms?
Often yes. Clonidine’s alpha-2 agonism reduces sympathetic nervous system arousal — the hyperarousal pattern that’s prominent in both ADHD and PTSD. For adults with both conditions, clonidine can address: hypervigilance, sleep disturbance from nightmares or anxiety, autonomic dysregulation, the constant alert-state that drives both ADHD-related fatigue and PTSD-related exhaustion. Combined ADHD-PTSD treatment often includes clonidine as one component. The mechanism is the same nervous-system calming that helps tics, sleep, and sensory dysregulation.
Should I try Intuniv before clonidine?
Generally yes, for ADHD alone. Intuniv (guanfacine) is typically preferred over clonidine for pure ADHD because: more selective receptor action means better ADHD-specific effects with less sedation; once-daily dosing is easier to maintain than multiple daily doses; the side-effect profile is generally better tolerated. Clonidine becomes the right choice when ADHD has prominent co-occurring features (severe insomnia, tic disorders, PTSD hyperarousal, sensory dysregulation) where the broader receptor profile and stronger sedation are useful. For specific clinical scenarios clonidine outperforms Intuniv. See our Intuniv for ADHD guide for the sibling comparison.